.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Fish and Richardson
AstraZeneca
Baxter
Chubb
Harvard Business School
Boehringer Ingelheim
Queensland Health
Teva
Daiichi Sankyo

Generated: July 23, 2017

DrugPatentWatch Database Preview

Glenmark Generics Company Profile

« Back to Dashboard

What is the competitive landscape for GLENMARK GENERICS, and what generic and branded alternatives to GLENMARK GENERICS drugs are available?

GLENMARK GENERICS has sixty-eight approved drugs.

There are three tentative approvals on GLENMARK GENERICS drugs.

Summary for Applicant: Glenmark Generics

Patents:0
Tradenames:59
Ingredients:54
NDAs:68
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Generics
NILSTAT
nystatin
SUSPENSION;ORAL050299-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Glenmark Generics
TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE
trandolapril; verapamil hydrochloride
TABLET, EXTENDED RELEASE;ORAL079135-003May 5, 2010ABRXNoNo► Subscribe► Subscribe
Glenmark Generics
IMIQUIMOD
imiquimod
CREAM;TOPICAL201994-001Mar 6, 2012ABRXNoNo► Subscribe► Subscribe
Glenmark Generics
LITHIUM CARBONATE
lithium carbonate
TABLET, EXTENDED RELEASE;ORAL091616-001Feb 14, 2011ABRXNoNo► Subscribe► Subscribe
Glenmark Generics
ESZOPICLONE
eszopiclone
TABLET;ORAL091166-001Apr 15, 2014ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for GLENMARK GENERICS drugs

Drugname Dosage Strength Tradename Submissiondate
omeprazole
Delayed-release Tablets20 mg
OMEPRAZOLE
6/3/2015

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
UBS
Cantor Fitzgerald
QuintilesIMS
Colorcon
AstraZeneca
Citi
McKesson
US Army
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot